DATE: July 12th 2017
TIME:  9:00AM SGT, 12:00PM AEDT

OR

DATE: July 11th, 2017
TIME:  6:00PM PDT

Evaluation of different options will be presented for scaling up large quantities of bone marrow-derived MSCs (BMSCs) using methods that can be performed in compliance with Good Manufacturing Practices (GMP).Topics covered will include cell yields, cost, time,
effort and ease of use with either automated or manual methods to manufacture enough BMSC to administer a single dose of 100 x 10^6 cells per patient.

Learning Objective:

• Cost-benefit analysis for manual versus automated MSC manufacturing for Phase I and
  II clinical trials